Boquoi, A.; Rings, V.; Mohring, A.; Savickaite, I.; Zukovs, R.; Strapatsas, J.; Nachtkamp, K.; Kobbe, G.; Germing, U.; Fenk, R.
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations. Cancers 2022, 14, 2147.
https://doi.org/10.3390/cancers14092147
AMA Style
Boquoi A, Rings V, Mohring A, Savickaite I, Zukovs R, Strapatsas J, Nachtkamp K, Kobbe G, Germing U, Fenk R.
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations. Cancers. 2022; 14(9):2147.
https://doi.org/10.3390/cancers14092147
Chicago/Turabian Style
Boquoi, Amelie, Veronika Rings, Annemarie Mohring, Ingrida Savickaite, Romans Zukovs, Judith Strapatsas, Kathrin Nachtkamp, Guido Kobbe, Ulrich Germing, and Roland Fenk.
2022. "Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations" Cancers 14, no. 9: 2147.
https://doi.org/10.3390/cancers14092147
APA Style
Boquoi, A., Rings, V., Mohring, A., Savickaite, I., Zukovs, R., Strapatsas, J., Nachtkamp, K., Kobbe, G., Germing, U., & Fenk, R.
(2022). Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations. Cancers, 14(9), 2147.
https://doi.org/10.3390/cancers14092147
